Hospitals and Clinics End User Segment to Dominate Creatinine Assay Market During Forecast Period
Increasing prevalence of
diabetes and chronic kidney disorders to drive the growth of global creatinine
assay market
According
to TechSci Research report, “Global Creatinine
Assay Market By Disease (Type 1 Diabetes, Type 2 Diabetes, Kidney disease,
Others), By Method (O'Leary modified Jaffe assay, Jaffe, Enzymatic),By Kit
(Creatinine-pap test kits, ELISA test kits, Jaffe’s kinetic test kits,
Creatinine Colorimetric/Fluorometric Assay Kit), By Sample (Serum, Urine,
Cerebrospinal fluid (CSF), Others), By End-User (Hospitals and clinics,
Diagnostic laboratories, Others), By Region, Forecast & Opportunities, 2025”, the global creatinine assay market is expected to grow at a
formidable rate during the forecast period on account of the increasing
prevalence of diabetes, which has led to the increase in the number of patients
suffering from renal diseases. Additionally, growing R&D activities coupled
with an increase in the number of clinical laboratories around the globe is
expected to propel the market during forecast years. Furthermore, improving
healthcare facilities and growing awareness among the population pertaining to
diabetes and renal diseases is expected to bolster the demand over the next few
years. However, limited usage of creatinine assay kits in in vitro diagnostic
devices can hampers the growth of market during the next five years.
Additionally, discovery of new biomarkers for identification of renal
dysfunction also restrict the growth of market through 2025. Furthermore,
constantly changing regulatory policies are expected to obstruct the growth of
market over next few years.
Browse
XX market data Tables and XX Figures spread through XXX
Pages and an in-depth TOC on" Global
Creatinine Assay Market"
https://www.techsciresearch.com/report/creatinine-assay-market/4535.html
The global creatinine assay market is segmented based on disease,
method, kit, sample, end user, company and region. Based on method, the market
can be fragmented into O'Leary modified jaffe assay, jaffe and enzymatic. The jaffe
method is expected to hold a significant market share during forecast period on
account of low cost of method and easy availability of the reagents and kits
used in this method. Based on kit, the market can be categorized into creatinine-pap
test kits, ELISA test kits, Jaffe’s kinetic test kits and creatinine
colorimetric/fluorometric assay kit. The jaffe’s kinetic test kits segment
dominates the market since jaffe’s method is the most conventional and most
widely used method for measurement of creatinine. Hence, this increases the
demand for jaffe’s kinetic test kits. Based on sample, the market can be
grouped into serum, urine, cerebrospinal fluid (CSF) and others. The urine
sample segment is expected to hold significant market share owing to ease of
sample availability and non-invasive method of sample collection. The serum
segment is expected to register the highest CAGR during the forecast period.
This can be ascribed to the better results accuracy. Based on end user, the
market can be segmented into hospitals and clinics, diagnostic laboratories and
others. The hospitals and clinics segment are expected to dominate the market
owing to the growing incidence of kidney diseases coupled with surge in number
of hospital admissions. Furthermore, growing patient preference towards
hospitals settings for disease detection and treatment will favor segment
growth.
BioVision, Thermo Fisher Scientific, Merck, Bioassay Systems, Cell
Biolabs, Fujifilm, Quidel Corporation, Enzo Life Sciences, Tulip Diagnostics,
Genway Biotech, Crystal Chem, Randox Laboratories, Nova Biomedical, Cayman
Chemical, Pfizer, DiaSys Diagnostic Systems, Abbexa, MedTest DX, Roche, Abcam and
others are some of the leading players operating in global creatinine assay market. The companies operating in the market are using organic
strategies such as product launches, mergers and collaborations to boost their
share.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4535
Customers can also request for 10% free customization on
this report.
“Asia-Pacific is expected to witness
the highest growth in the creatinine assay market during the forecast period,
owing to the increasing prevalence of chronic kidney diseases, diabetes and ageing
population. Additionally, economic growth in countries like India and China is
supporting the health care infrastructure as well as expansion of
pharmaceutical companies and biotech labs in these countries. Also, growing
focus of market players on addressing demands in these countries is further
expected to foster the growth of market through 2025.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research based global management consulting firm.
“Global Creatinine Assay Market By Disease (Type 1
Diabetes, Type 2 Diabetes, Kidney disease, Others), By Method (O'Leary modified
Jaffe assay, Jaffe, Enzymatic),By Kit (Creatinine-pap test kits, ELISA test
kits, Jaffe’s kinetic test kits, Creatinine Colorimetric/Fluorometric Assay
Kit), By Sample (Serum, Urine, Cerebrospinal fluid (CSF), Others), By End-User
(Hospitals and clinics, Diagnostic laboratories, Others), By Region, Forecast
& Opportunities, 2025” has
evaluated the future growth potential of global creatinine assay market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges and opportunities in global creatinine assay market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]